Makarov G I, Reshetnikova R V
South Ural State University, 454080, Chelyabinsk, Russia.
South Ural State University, 454080, Chelyabinsk, Russia.
J Mol Graph Model. 2021 Jun;105:107902. doi: 10.1016/j.jmgm.2021.107902. Epub 2021 Mar 21.
Radezolid is a promising antibiotic of oxazolidinone family, which is able to overcome effect of some linezolid resistance mechanisms of bacterial ribosomes. The structure of the radezolid complex with ribosomes was never published but, by analogy with linezolid, it is considered to prevent the binding of aminoacyl-tRNA to the A-site of the ribosome large subunit. However, as with linezolid, it can be assumed that radezolid binds to the alternative binding site existing in the A,A/P,P-ribosome. In the present article we have investigated this issue by molecular dynamics simulations and proposed the structure of the radezolid complex with a E. coli ribosome, which is consistent with available data of biochemical investigations of radezolid action.
瑞地唑胺是一种有前景的恶唑烷酮类抗生素,能够克服细菌核糖体某些对利奈唑胺耐药机制的影响。瑞地唑胺与核糖体复合物的结构从未发表过,但根据与利奈唑胺的类比,它被认为可阻止氨酰基-tRNA与核糖体大亚基的A位点结合。然而,与利奈唑胺一样,可以推测瑞地唑胺与存在于A、A/P、P核糖体中的替代结合位点结合。在本文中,我们通过分子动力学模拟研究了这个问题,并提出了瑞地唑胺与大肠杆菌核糖体复合物的结构,这与瑞地唑胺作用的现有生化研究数据一致。